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Abstract 9 
Dicationic ionic liquids (ILs) generally possess higher thermal and electrochemical stability than 10 
the analogous monocationic ILs, which makes them more suitable for high-temperature 11 
applications as solvents for organic reactions, lubricants or stationary phase in gas 12 
chromatography. However, knowledge on dicationic IL cytotoxicity is still scarce. Here we 13 
explore the cytotoxicity of twelve mono- and dicationic pyridinium-based ILs on HeLa, MCF-7, 14 
BGM and EA.hy926 cells. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 15 
(MTT) assay, cell cycle arrest assays, apoptosis experiments and orange staining were carried out. 16 
The results showed that dicationic ILs are generally less cytotoxic than their monocationic 17 
counterparts. In monocationic ILs, cytotoxicity was stronger when they contain long alkyl chains, 18 
because of their higher lipophilicity. However, the full effect of the length of the linkage alkyl 19 
chain of dicationic ILs on cytotoxicity is not clear probably because the chain is “trapped” 20 
between both cationic moieties. IL cytotoxicity is highly dependent on the cell type, and HeLa 21 
cells exposed to [C12Pyr]Br die via apoptosis. The present study increases our knowledge of IL 22 
cytotoxicity on human and monkey cells and clarifies the cell death mechanism. The results 23 
suggest that dicationic ILs offer the potential to replace some monocationic ILs because of their 24 
lower cytotoxicity. 25 
Keywords: Dicationic; ionic liquid; pyridinium; MTT assay; apoptosis.  26 
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1. Introduction 27 
Ionic liquids (ILs) are molten salts at low temperature (around or below 100 ºC). Low melting 28 
points are possible because the asymmetry of their ionic structure and the dispersion of their 29 
charges result in reduced inter-ion interaction energies and decreased lattice enthalpy (HL) 30 
(Ranke et al., 2004). ILs are typically composed of an organic cation with a bulky charge-carrying 31 
head group (imidazolium, pyrrolidinium, pyridinium, piperidinium, etc.) and one or more alkyl 32 
side chains, and a counterion which may be organic or inorganic, for example Cl-, Br-, AcO- or 33 
[Tf2N]- (Wu et al., 2018). ILs have been widely studied in research activities and even 34 
incorporated into several industrial processes because of their exclusive combination of 35 
properties, which include negligible vapor pressure, non-flammability, wide liquid state 36 
temperature range, high thermal and chemical stability and high ionic conductivity (Alvarez-37 
Guerra and Irabien, 2011; Diaz et al., 2018; Lee and Lin, 2014). On a fundamental level, the most 38 
remarkable feature of ILs is the possibility of modulating their physicochemical properties, 39 
including their hydrophobicity, viscosity, density or solubility and their biodegradability or 40 
toxicity, by means of the appropriate selection of the cationic and anionic constituents (Montalbán 41 
et al., 2015; Ventura et al., 2012), which means that they can be designed for a specific application 42 
(Viswanathan et al., 2006). Initially ILs were proposed as more benign solvents and candidates 43 
to replace conventional organic solvents (Earle and Seddon, 2002), but they have also found 44 
applications in other areas, where they can be used as reaction media (de Los Ríos et al., 2007), 45 
catalysts (Welton, 2004), extraction agents (Montalbán et al., 2018a, 2016a) or supported liquid 46 
membranes (Hernández-Fernández et al., 2008, 2007), and in lithium ion batteries (Balducci, 47 
2017), dye-sensitized solar cells (Denizalti et al., 2018) or the synthesis of biopolymeric 48 
nanoparticles (Lozano-Pérez et al., 2015). 49 
Dicationic ILs are an interesting sub-class of materials that can be easily prepared by the 50 
functionalization of a central linker fragment with two discrete cationic charge carriers 51 
(Montalbán et al., 2018b; Steudte et al., 2014). Compared to monocationic ILs, dicationic ILs 52 
may possess even higher thermal and moderately increased electrochemical stability, making 53 
3 
 
them more suitable for use in high-temperature applications as solvents for reactions (Han and 54 
Armstrong, 2005), lubricants (Jin et al., 2006) or as stationary phases in gas chromatography (Qi 55 
and Armstrong, 2007). Because ILs are widely used in academic research and have potential use 56 
in industry, more studies related to their toxicity are required since they may enter to the living 57 
environment and the risks associated with them are still far from being known in any depth (Wu 58 
et al., 2018), especially in the case of the more recently discovered dicationic ILs. As mentioned 59 
above, the release of ILs into the atmosphere is difficult because they are not volatile (Gómez-60 
Herrero et al., 2018). However, a great number of ILs (all those which are hydrophilic), are 61 
notably soluble in water and hence bioavailable so they can easily enter water streams or soils 62 
(Diaz et al., 2018; Montalbán et al., 2016b) with serious effects on human health and the 63 
environment. By contrast, ILs which contain a hydrophobic anion (PF6-, Tf2N-, among others) are 64 
practically non-soluble in water and have poor bioavailability. ILs with halogen anions (chloride, 65 
bromide or iodide), such as the ILs studied in this work, are highly hydrophilic and extremely 66 
water soluble, with a high degree of bioavailability (Huddleston et al., 2001). Given the wide 67 
potential use of mono- and dicationic ILs in industrial processes, especially as an alternative to 68 
conventional solvents, and their possible release into the environment by accidental spills or as 69 
residues, analysis of their toxicological fate is imperative. In addition, some ILs have recently 70 
been seen to be of interest in the biological and pharmaceutical field as platforms to overcome 71 
problems associated with new drugs, such as their low solubility in water and poor bioavailability 72 
(Egorova et al., 2017; Vieira et al., 2019). To this end, several studies have reported that ILs are 73 
able to increase the water solubility of poorly soluble drugs because of their capacity for 74 
dissolving pharmaceutical ingredients and for acting as drug reservoirs in controlled release 75 
devices (Mahkam et al., 2016; Miwa et al., 2016; Mizuuchi et al., 2008; Moniruzzaman et al., 76 
2010). New dicationic imidazolium-based ILs have recently been synthesized and their potential 77 
use as antimicrobial materials has been demonstrated (Gindri et al., 2014). These recent 78 
applications of ILs make the study of their biocompatibility and cytotoxicity even more necessary.  79 
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Studies related to the toxicity of dicationic ILs are very scarce in the literature. e Silva et al. (2014) 80 
studied the (eco)toxicity of dicationic cholinum-based ILs in Vibrio fischeri on the basis of the 81 
luminescence inhibition of this bacterium. Steudte et al. (2014) used several toxicity tests of 82 
different levels of biological complexity to study a group of dicationic imidazolium and 83 
pyrrolidinium-based ILs. They used enzyme inhibition tests (acetylcholinesterase), algae 84 
(Scenedesmus vacuolatus), fish (Daphnia magna) and cell lines (IPC-81) to carry out the 85 
experiments. Gindri et al. (2014) screened the cytotoxicity of a set of dicationic imidazolium-86 
based ILs on MC3T3-E1 pre-osteoblast cells. 87 
In this study, we evaluate the cytotoxicity of 10 pyridinium-based ILs (5 dicationic ILs and their 88 
monocationic counterparts) on four cell lines: Human cervical cancer cells (HeLa), Human breast 89 
cancer cells (MCF-7), green monkey kidney epithelial cells (BGM) and human umbilical 90 
immortalized cells (EA.hy926). A comparison between the cytotoxicity of dicationic and 91 
monocationic ILs is carried out in order to study the influence of the dicationic moiety structure, 92 
while the effect of the alkyl chain length and cell line on cytotoxicity in both groups of ILs is also 93 
analyzed. To the best of our knowledge, this is the first time that the cytotoxicity of these 94 
dicationic ILs has been measured. 95 
2. Material and Methods 96 
 97 
2.1.  Ionic liquids 98 
The full name and chemical structure of the ILs used are presented in Table 1. The monocationic 99 
ILs [C2Pyr]Br (purity>99%), [C4Pyr]Br (purity>99%), [C6Pyr]Br (purity>99%), [C8Pyr]Br 100 
(purity>99%) and [C12Pyr]Br (purity>99%) were purchased from IoLiTec (Germany). The 101 
dicationic ILs used in this study ([C2(Pyr)2]Br2, [C4(Pyr)2]Br2, [C6(Pyr)2]Br2, [C8(Pyr)2]Br2 and 102 
[C12(Pyr)2]Br2)  were synthesized and characterized as described in previous papers (Montalbán 103 
et al., 2018b; Montalbán et al., 2018c). 104 





IL full name Cation Anion 
[C2Pyr]Br 1-ethylpyridinium bromide 
 
Br- 
[C4Pyr]Br 1-butylpyridinium bromide 
 
Br- 
[C6Pyr]Br 1-hexylpyridinium bromide 
 
Br- 
[C8Pyr]Br 1-octylpyridinium bromide 
 
Br- 





























2.2. Cell lines and culture media 107 
Human cervical cancer cells (HeLa), Human breast cancer cells (MCF-7), green monkey kidney 108 
epithelial cells (BGM) and human umbilical immortalized cells (EA.hy926) were acquired from 109 
the American Type Tissue Culture Collection (ATCC, USA). Cell lines were maintained in 110 
Dulbecco’s Modified Eagle Medium (DMEM) with a low glucose content (1 g/L) supplemented 111 
with 10% (v/v) fetal bovine serum (FBS), 1 mM glutamax, 1 % antibiotics (penicillin-112 
streptomycin) and 1 mM pyruvate. In all cases, cells were maintained at 37ºC in 5% CO2 with 113 
95% humidity atmosphere. Cells were sub-cultured and the medium was changed once a week. 114 
In all cases, 0.25% trypsine-0.25 mM ethylenediaminetetraacetic acid (EDTA) were used. Before 115 
6 
 
and after the experiments, all cell lines were seen to be mycoplasma-free, as determined by the 116 
Hoechts DNA stain method (Chen, 1976).  117 
 118 
2.3.  Cytotoxicity assay 119 
 120 
A total of 5×103 cells/well (150 L of culture medium as described above) were seeded in a 96-121 
well plate and incubated at 37 ºC in a 5% CO2 and 95% humidity atmosphere for 24 h. The IL 122 
solutions were diluted in complete medium at 100 mM concentration for dicationic ILs and 250 123 
µM for the monocationic ILs. The resulting solution was then diluted successively (1:1 dilutions) 124 
to obtain a total of 16 solutions of diminishing concentration. These dilutions differed depending 125 
on the IL in question and their cytotoxic effect on each cell line. The dilutions were added to each 126 
well at a final volume of 150 µL. Cells were incubated at 37 ºC for 48 h. The medium was then 127 
removed from the wells and 200 L of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-128 
diphenyltetrazolium bromide, 1 mg/mL final concentration) was added. After 4 h incubation in 129 
identical conditions, MTT was removed and 100 L of dimethyl sulfoxide (DMSO) was added. 130 
The absorbance at 560 nm was then recorded on a Fluostar Omega spectrophotometer. 131 
The absorbance at each compound concentration was translated into inhibition percentage, I%, 132 
according to the following equation, 133 
𝐼% =  [1 −
𝐴𝑇
𝐴𝐶
] 𝑥100                          [1] 134 
where AT and AC are the absorbances of treated and control cells, respectively. 135 
IC50 values were obtained from a three parameter fitting of the semi-logarithmic curves (I% as a 136 






𝑛                             [2] 138 
where Imax is the maximum inhibition observed, IC50 is the IL concentration at which 50% of the 139 
cell population is dead, C is the IL concentration at which the inhibition I% is observed and n is 140 
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the slope of the curve at the IC50 value. The fitting was performed using GraphPad Prism v.6 141 
software. All compounds were tested in three independent sets with triplicate points. The in vitro 142 
studies were performed in the SACE service with Level 2 Biosecurity (Support Service for 143 
Experimental Sciences, University of Murcia, Murcia, Spain).  144 
2.4. Cell Cycle Arrest Assays  145 
A total of 7.5×104 HeLa cells were seeded in 12-well plates and left at 37C in a 5% CO2 and 95% 146 
humidity atmosphere for 24 h. Monocationic or dicationic ILs with C12 chain used at the 147 
approximate IC50 concentration were then added to each well. Cells were incubated for 24 h and 148 
then removed from the wells with trypsin-EDTA, collected and centrifuged (200g, 5 min). The 149 
supernatant was removed and the cells were washed with phosphate-buffered saline (PBS) and 150 
centrifuged (200g, 5 min). The supernatant was also removed, and the cells were treated with 151 
ethanol (EtOH) at 70% (PBS, 30%) for 45 min at 4ºC. Finally, EtOH was removed by 152 
centrifugation. Cells were resuspended in 400 µL of PBS, and 50 µL RNase solution and 50 µL 153 
of propidium iodide (PI) were added at a final concentration of 0.1 mg/mL and 40 mg/mL, 154 
respectively. Cells were incubated for 30 min in the same conditions as for culture. The PI 155 
fluorescence was measured for each cell in a Becton-Dickinson FACScalibur flow cytometer. In 156 
each case 30000 events were acquired. 157 
2.5. Apoptosis Experiments  158 
To explore the cell death mechanism provoked by ILs, apoptosis experiments were performed. 159 
First, 7.5×104 of HeLa cells were typically seeded in a 12-well plate and maintained under normal 160 
culture conditions. After 24 h, the cells were treated with monocationic and dicationic ILs with 161 
C12 chain at the approximate IC50 concentration and incubated for a further 24 h. An apoptosis 162 
positive control with 8 µM camptotecin was used. Following incubation, media and cells were 163 
collected and centrifuged, the supernatant was discarded and cells were washed twice with PBS 164 
as described above (without the PBS/EtOH mix in this case). After removing the PBS, 40 μL of 165 
a solution containing Annexin V and PI (Annexin-V-Fluos from Roche) and 160 μL of incubation 166 
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buffer (Roche apoptosis kit) were added to the cell pellet. Cells were resuspended in this solution 167 
and left at room temperature in the dark for 15 min. 200 μL of PBS was added prior to determining 168 
the emission of PI and Annexin V at 620 and 525 nm, respectively. These measurements were 169 
carried out in a Becton-Dickinson FACScalibur flow cytometer. In each case, 10000 events were 170 
acquired. 171 
2.6. Nuclei fluorescent imaging 172 
Typically, 1,5x104 HeLa cells were cultured in the same conditions as described above (DMEM 173 
supplemented, 37ºC, 5% CO2 and 95-100% humidity) in a 4-well chamber slide system and left 174 
for 24 h. [C12Pyr]Br was then added at 8 µM and the cells in each individual well were fixed every 175 
30 minutes with 70% alcohol and left in PBS buffer. Finally, a solution of 1ng/ml of acridine 176 
orange was added to each well, and the resulting cultures were incubated for 10 min. The resulting 177 
slide was observed under an inverted microscope (NIKON mod. Eclipse TE 2000U) for phase 178 
contrast and using a FITC filter for fluorescent images. Imaging cells were analyzed with ImageJ 179 
software. The statistical analysis was made with GraphPad Prims 6 software. 180 
 181 
3. Results and Discussion 182 
3.1. Cytotoxicity of mono- and dicationic pyridinium-based ILs 183 
Carrying out in vitro cytotoxicity tests is important in the case of ILs and, especially when they 184 
are going to be used in biological and pharmaceutical applications and in other areas in which 185 
they could come into contact with humans, animals or the environment. The test is cost-effective, 186 
convenient and time saving (Vieira et al., 2019). IL cytotoxicity is greatly influenced by the 187 
chosen cell line and by IL structural features such as the cationic moiety, the length of the alkyl 188 
chain/s and the anion type (Wu et al., 2018). After exposing HeLa, MCF-7, BGM and EA.hy926 189 
cells to a series of mono- and dicationic pyridinium-based ILs for 48 hours, IC50 values were 190 
calculated using a dose-response model, which was obtained from a sigmoidal fitting of dose-191 
response curves as stated in Section 2.3. The calculated IC50 values are shown in Table 2. The 192 
corresponding dose-response curves of monocationic and dicationic ILs are represented in 193 
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Figures 1 and 2, respectively. It can be observed that the cytotoxicity of the ILs was dose-194 
dependent. The IC50 of [C12Pyr]Br on EA.hy926 cells was the lowest, with a value of 0.1 µM. By 195 
contrast, the IC50 of [C4(Pyr)2]Br2 on MCF-7 cells was the highest at 33.17 mM. From a 196 
preliminary study of the results, we can infer that the IL cytotoxicity greatly depends on the IL 197 
structure and on the cell line in question. As a general rule, the IC50 values obtained in this work 198 
were high, reflecting the low cytotoxicity of the studied ILs and the probability that, at their 199 
environmental concentration, they have no strong cytotoxic effect. 200 
Table 2. IC50 values for HeLa, MCF-7, BGM and EA.hy926 cells exposed to mono- and 201 




HeLa MCF-7 BGM EA.hy926 
[C2Pyr]Br 5.560±0.4307  26.300 ±5.8194  4.743±0.9068 6.511±0.4474 
[C4Pyr]Br 1.725 ±0.1771  6.439 ±0.8727  3.756 ±0.7244 1.998 ±0.2059 
[C6Pyr]Br 0.568±0.0707  3.262 ±0.5238  0.690±0.1487 0.228 ±0.03627 
[C8Pyr]Br 0.0159±0.0018 0.054±0.0047  0.211±0.0208 0.0007 ±0.0001 
[C12Pyr]Br 0.0046±0.0002 0.002±0.0002 0.018±0.0037 0.0001±0.00002 
[C2(Pyr)2]Br2 18.360 ± 0.529  6.553 ± 2.797  13.220 ± 0.529 22.100 ± 1.971 
[C4(Pyr)2]Br2 13.760 ± 1.218  33.170 ± 2.696 22.140 ± 0.336 19.560 ± 1.381 
[C6(Pyr)2]Br2 18.250 ± 0.641  17.410 ± 1.458  24.000 ± 1.033 8.428 ± 2.659 
[C8(Pyr)2]Br2 1.078 ± 0.141 6.979 ± 0.716  26.260 ± 0.249 0.408 ± 0.037 






Figure 1. Dose-response curves of HeLa, MCF-7, BGM and EA.hy926 cells treated with five 207 




Figure 2. Dose-response curves of HeLa, MCF-7, BGM and EA.hy926 cells treated with five 212 
dicationic pyridinium-based ILs for 48 hours. 213 
3.1.1. Monocationic vs dicationic ILs 214 
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To study the effect of the presence of one or two cationic moieties on the cytotoxicity of ILs, the 215 
cell viability of HeLa, MCF-7, BGM and EA.hy926 cells after treatment with five monocationic 216 
ILs and their five homologous dicationic ILs was evaluated. As can be seen in Figure 3, all the 217 
dicationic ILs studied showed higher IC50 values than their monocationic homologues, except 218 
[C2(Pyr)2]Br2 on MCF-7 cells, and the difference was more pronounced as the alkyl chain length 219 
of the cation increased. These results agree with those of other authors, who observed that an 220 
additional cationic head reduced the IL toxicity compared with the corresponding monocationic 221 
IL (Gindri et al., 2014; Steudte et al., 2014). According to Gindri et al. (2014), in dicationic ILs, 222 
the alkyl chain, the length of which probably governs the cytotoxicity (McLaughlin et al., 2011), 223 
is masked between the two cationic moieties, losing its ability to interact with cell membranes 224 
and, therefore, reducing IL cytotoxicity. A similar conclusion was reached in IL (eco)toxicity 225 
studies (e Silva et al., 2014; Montalbán et al., 2018b). e Silva et al. (2014) suggested that the lower 226 
(eco)toxicity of dicationic ILs on Vibrio fischeri could be related to the bigger size of the 227 
molecules, which would hinder their interaction with the bacterial cell membranes. In addition, 228 
the second charge carrier stops the carbon chain, reducing the toxic potency (Montalbán et al., 229 
2018b). This lower cytotoxicity of dicationic ILs constitutes an important advantage because it 230 
means that they can be specifically designed as alternatives to monocationic ILs, for biological 231 




Figure 3. IC50 values for HeLa, MCF-7, BGM and EA.hy926 cells exposed to monocationic and 234 
dicationic pyridinium-based ILs with different alkyl chain lengths (the number of carbon atoms n 235 
ranged from C2 to C12) for 48 hours.  236 
3.1.2. Influence of alkyl chain length 237 
The cytotoxic effect of monocationic and dicationic pyridinium-based ILs with different alkyl 238 
chain lengths (number of carbon atoms n = 2, 4, 6, 8 and 12) on HeLa, MCF-7, BGM and 239 
EA.hy926 cells was studied. The results are shown in Figure 3. In the case of the monocationic 240 
ILs, their cytotoxicity on all the cell lines increased with the alkyl chain length as their IC50 values 241 
decreased. The link between increasing alkyl chain length and increasing cytotoxicity in 242 
monocationic ILs has been established in numerous studies (Li et al., 2012; McLaughlin et al., 243 
2011; Steudte et al., 2014; Vieira et al., 2019; Wu et al., 2018). Lengthening of the alkyl chain of 244 
the cation is closely related to an increase in IL toxicity due to the increase of lipophilicity (Gal 245 
et al., 2012; Montalbán et al., 2016b). This increase in the lipophilic nature and the presence of 246 
delocalized charges would promote the disruption of the cell membrane and increase the internal 247 
acidity, with negative effects on cellular viability because of enzyme denaturation and oxidative 248 
stress (Gal et al., 2012; Vieira et al., 2019). According to Wu et al. (2018), the stronger the 249 
lipophilicity, the greater the possibility of contact with the lipid bilayer and hydrophobic proteins 250 
of the membrane, altering its normal physiological function and even leading to cell death.  251 
As regards the dicationic ILs (Figure 3), a similar trend was found, but not so clear. With up to 252 
six carbon atoms in the alkyl chain, the IC50 of [C2(Pyr)2]Br2, [C4(Pyr)2]Br2 and [C6(Pyr)2]Br2 on 253 
EA.hy926 and HeLa cells showed values of the same order of magnitude and, from [C8(Pyr)2]Br2, 254 
cytotoxicity greatly increased. In BGM and MCF-7 cell lines, the IL cytotoxicity did not start to 255 
significantly increase until [C12(Pyr)2]Br2. On the one hand, our results agree with other authors 256 
such as Gindri et al. (2014), who found that imidazolium-based dicationic ILs with different 257 
anions and cationic alkyl chains of 10 carbons were more toxic towards MC3T3-E1 pre-osteoblast 258 
cells than those with 8 carbons. On the other hand, the trend observed in this work was also found 259 
by Steudte et al. (2014) who reported that they did not observe the effect of greater toxicity on 260 
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promyelocytic leukemia rat cells (IPC-81) with increasing spacer length from 2 to 6 atoms of 261 
carbons in the studied dicationic ILs. However, they did find an effect when the length of the 262 
terminal side chains (not the linkage alkyl chain) increased from 1 to 5 atoms of carbons. The 263 
reason might be that, as stated before, the alkyl chain is “trapped” between the two cationic 264 
moieties and, although the hydrophobicity of the cation increases with the length of the linkage 265 
alkyl chain, the interaction of the alkyl chain with the cellular membrane is weaker and, 266 
consequently, cellular death is reduced. 267 
3.1.3. Influence of cell type 268 
In this study, the cell lines were selected due to their features and origin. Three of them (HeLa, 269 
MCF-7 and EA.hy926) were human cell lines and one of them (BGM) from monkey. HeLa cells 270 
are derived from cervical carcinoma and represent prototypical cells of the human epithelium. 271 
Epithelial cells were chosen because toxic compounds generally enter an organism through this 272 
site of first contact so they are a suitable model for studying IL cytotoxicity on human cells due 273 
to the direct contact (Stepnowski et al., 2004; Xia et al., 2018). MCF-7 cells are human breast 274 
cancer cells, which have been widely used in IL cytotoxicity studies because they are a well-275 
characterized cell line (Kumar et al., 2008; Salminen et al., 2007). EA.hy926 cells coat the inside 276 
of blood vessels and are one of the most used and best characterized human vascular endothelial 277 
cell lines (Vieira et al., 2019). When ILs are used in pharmacological approaches with intravenous 278 
administration, the determination of IL cytotoxicity on endothelial vein cells such as EA.hy926 279 
cells is of great value. BGM is a cell line of renal origin. It is a non-tumorigenic epithelial cell 280 
line which was chosen because it is a good reference to assess the toxicological effects of different 281 
compounds (Romero et al., 2004). 282 
As can be seen in Figure 4 and Table 1, the IL cytotoxic effect is greatly influenced by the cell 283 
line, but the mechanism of IL cytotoxicity has not been fully elucidated yet. A similar conclusion 284 
was reached by other authors (Vieira et al., 2019). According to our results, it may be inferred 285 
that EA.hy926 cells are more sensitive to mono- or dicationic ILs with longer alkyl chains (C6-286 
14 
 
C12), i.e. the most toxic of each series, while the cytotoxicity exhibited toward normal and cancer 287 
human cells is significantly different. For mono- or dicationic ILs with shorter alkyl chains (C2-288 
C4), the cytotoxicity values are of the same order on all the cell lines and no trend can be 289 
established. The differences in the cellular viability of the different cell lines after exposure to the 290 
same IL could derive from the specific features and/or properties of the cells. 291 
292 
Figure 4. IC50 values for HeLa, MCF-7, BGM and EA.hy926 cells exposed to monocationic (left) 293 
and dicationic (right) pyridinium-based ILs for 48 hours. 294 
 295 
3.2. Flow cytometry analysis of mono- and dicationic pyridinium-based ILs 296 
For the flow cytometry analysis, HeLa cells were chosen as a model for their well-characterized 297 
cell cycle. As comparison between mono- and dicationic ILs, the assays were carried out with 298 
[C12Pyr]Br and [C12(Pyr)2]Br2 since they are the most toxic ILs on HeLa cells in each series. The 299 
IC50 concentration of both ILs was chosen for the experiments. 300 
3.2.1. Rate of apoptosis 301 
To analyze the nature of cell death due to the effect of the ILs on HeLa cells, Annexin-V-Fluos 302 
Apoptosis Detection Kit was used to determine the rate of apoptosis provoked by 24 hours of 303 
treatment at the IC50 concentration of [C12Pyr]Br and [C12(Pyr)2]Br2. The Annexin-V-Fluos 304 
stained graph consists of four quadrants (Q) where Q1 represents necrotic cells, Q2 and Q3 show 305 
late and early apoptotic cells, respectively and Q4 are the live cells. As negative control live HeLa 306 
cells which had not been treated with any IL were used, and the positive control, as mentioned in 307 
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Section 2.5, was HeLa cells treated with camptotecin, a chemical compound which induces 308 
cellular apoptosis. The positive control is normally used as comparison and, if similar results are 309 
found in the treated cells, it can be assumed that the cells have suffered apoptosis. As shown in 310 
Figure 5, the apoptotic effect in HeLa cells was dependent on the type of IL and its concentration. 311 
The apoptosis rate (Q2 + Q3) of the negative and positive controls was 19.82% and 56.9%, 312 
respectively. The apoptosis rate of the HeLa cells exposed to [C12Pyr]Br and [C12(Pyr)2]Br2 at 313 
their IC50 concentration was 24.92% and 30.3%, respectively. As expected, these values are 314 
intermediate between both controls, indicating that the mechanism acting during cell death was 315 
mainly apoptotic. In addition, it could be inferred that early apoptosis and late apoptosis were the 316 
main cell death mechanisms for the monocationic and the dicationic IL, respectively. The results 317 
reveal that, to reach a similar rate of apoptosis, a considerably higher dicationic IL concentration 318 
was necessary, showing again its less cytotoxic behavior compared to its monocationic analogous. 319 
 320 
 321 
Figure 5. Flow cytometry analysis of apoptosis rate in HeLa cells after 24 hours of treatment with 322 
different concentrations of [C12Pyr]Br and [C12(Pyr)2]Br2. HeLa cells not treated with IL were 323 




3.2.2. Influence of IL treatment on the cell cycle 326 
The observed induction of apoptosis due to pyridinium-based IL treatment on HeLa cells further 327 
prompted us to study the inhibition mechanism of cell growth through cell cycle arrest by flow 328 
cytometric analysis. The cell cycle of HeLa cells exposed to [C12Pyr]Br and [C12(Pyr)2]Br2 at the 329 
IC50 concentration for 24 hours was evaluated. According to Figure 6, the number of G1 phase 330 
cells slightly increased with respect to the control (unexposed cells) from 49.1% to 54.6 % and 331 
53.5% when cells were exposed to [C12Pyr]Br and [C12(Pyr)2]Br2, respectively. The number of 332 
cells in the S and G2/M phases decreased in both cases. The S cell number decreased from 27.7% 333 
to 23.4% and 24.5%, and the G2/M cell number from 16.6% to 13.1% and 13.3% with [C12Pyr]Br 334 
and [C12(Pyr)2]Br2, respectively. Our results are in good agreement with previous IL cytotoxicity 335 
studies. Thamke et al. (2019) reported that another pyridinium-based monocationic IL, 1-butyl-336 
4-methylpyridinium chloride, arrested animal cells (MDA-MB-231) in S and G2/M phases of the 337 
cell cycle. It can be concluded that the dicationic IL, [C12(Pyr)2]Br2, is much less cytotoxic than 338 
the homologous monocationic IL, [C12Pyr]Br, because a 32-fold concentration is necessary to 339 





Figure 6. The cell cycle of HeLa cells exposed to different concentrations of [C12Pyr]Br and 343 
[C12(Pyr)2]Br2 for 24 hours. HeLa cells not treated with IL were used as control.  344 
 345 
3.3. Nuclear morphology in HeLa cells after being exposed to [C12Pyr]Br 346 
Observing cellular morphology is useful for distinguishing between apoptosis and necrosis during 347 
cell death. The nucleus fluorescence of HeLa cells after different exposure times (0, 30, 60 and 348 
90 min) at a concentration of 8 μM of [C12Pyr]Br, the most toxic IL in this work, can be found in 349 
Figure 7. The quantitative analysis showed that the fluorescence remained constant up to 60 min 350 
of exposure. Only at 90 min was an increase in nucleus fluorescence observed, due to the 351 
alteration in nucleus morphology occurred. Cell nuclei increased in size, perhaps due to the 352 
significant G1 phase arrest of cell cycle progression. This provides an opportunity for cells to 353 
either undergo repair mechanisms or follow the apoptotic pathway (Murad et al., 2016). 354 
According to Huber and Gerace (2007) and Jorgensen et al. (2007), a critical nucleus size is 355 
required for progression between the G1 and S phases in eukaryotic cells. However, in this case, 356 
cell nuclei did not reach a critical size to progress to the S phase as shown in Figures 5 and 6. 357 
Therefore, we infer that [C12Pyr]Br at a concentration of 8 μM after 90 min of treatment induces 358 




Figure 7. Nuclear morphology in HeLa cells induced by [C12Pyr]Br at a concentration of 8 μM 361 
over 0, 30, 60 and 90 min using acridine orange staining. HeLa images correspond to the initial 362 
time and 90 min of treatment. 363 
 364 
4. Conclusions 365 
Some trends can be identified for the twelve monocationic and dicationic pyridinium-based ILs 366 
studied in this work. These are related to both their structural features and the cell line chosen to 367 
test their cytotoxicity. The results suggest that the cytotoxicity of the studied ILs on the four cell 368 
lines is highly dependent on their structure. The development of dicationic ILs, with a broad range 369 
of potential applications, but with lower cytotoxicity than their monocationic counterparts, can be 370 
considered in the sustainable design of new ILs for specific applications. The present results 371 
confirm that the mechanism of cell death followed by the most toxic IL used in this study, 372 
[C12Pyr]Br, on HeLa cells was apoptotic. In addition, this work increases our knowledge of the 373 
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